 Connection
Elizabeth Bayliss to Hypoglycemic Agents
This is a "connection" page, showing publications Elizabeth Bayliss has written about Hypoglycemic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.532 |
|
|
|
-
Raebel MA, Carroll NM, Ellis JL, Schroeder EB, Bayliss EA. Importance of including early nonadherence in estimations of medication adherence. Ann Pharmacother. 2011 Sep; 45(9):1053-60.
Score: 0.230
-
Bennett WL, Aschmann HE, Puhan MA, Robbins CW, Bayliss EA, Wilson R, Mularski RA, Chan WV, Leff B, Sheehan O, Glover C, Maslow K, Armacost K, Mintz S, Boyd CM. A benefit-harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions. J Clin Epidemiol. 2019 09; 113:92-100.
Score: 0.098
-
Maciejewski ML, Hammill BG, Bayliss EA, Ding L, Voils CI, Curtis LH, Wang V. Prescriber Continuity and Disease Control of Older Adults. Med Care. 2017 04; 55(4):405-410.
Score: 0.085
-
Schroeder EB, Hanratty R, Beaty BL, Bayliss EA, Havranek EP, Steiner JF. Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):645-53.
Score: 0.061
-
Raebel MA, Ellis JL, Carroll NM, Bayliss EA, McGinnis B, Schroeder EB, Shetterly S, Xu S, Steiner JF. Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders. J Gen Intern Med. 2012 Jan; 27(1):57-64.
Score: 0.058
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|